LAS VEGAS — In this video perspective from the ASCRS meeting, George O. Waring IV, MD, FACS, discusses phase 3 data from the GEMINI 1 study investigating AGN-190584 (pilocarpine 1.25%, Allergan) for the treatment of presbyopia.
Uncategorized
VIDEO: Waring discusses phase 3 results for presbyopia drop